These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 4303640

  • 1. [Bacteriostatic activity of preparations of the 2d series and criteria of the resistance to them].
    Mkrtchian SV, Afanas'eva IuP.
    Probl Tuberk; 1967; 45(8):70-5. PubMed ID: 4303640
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Chemotherapeutic activity and diffusion properties of the second series antituberculous preparations].
    Drabkina RO, Ginzburg TS.
    Klin Med (Mosk); 1966 Dec; 44(12):38-43. PubMed ID: 4302345
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment with new antitubercular agents].
    Gartmann J.
    Dtsch Med Wochenschr; 1968 Nov 22; 93(47):2281-2. PubMed ID: 4301079
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN, Gur'ian IE, Kochetov BI.
    Probl Tuberk; 1972 Nov 22; 50(11):21-4. PubMed ID: 4630564
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M.
    Bull Int Union Tuberc; 1968 Dec 22; 41():194-200. PubMed ID: 4303863
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S.
    Iryo; 1968 Oct 22; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract] [Full Text] [Related]

  • 16. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
    Tsukamura M.
    Kekkaku; 1978 Oct 22; 53(10):495-8. PubMed ID: 102861
    [No Abstract] [Full Text] [Related]

  • 17. Bacteriology of tuberculosis with special reference to kanamycin and related drugs.
    Dye WE.
    Ann N Y Acad Sci; 1966 Jun 14; 132(2):901-4. PubMed ID: 4290030
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of tuberculosis today in Nebraska.
    Burgher LW, Kass I.
    Nebr Med J; 1973 May 14; 58(5):156-62. PubMed ID: 4348990
    [No Abstract] [Full Text] [Related]

  • 19. Chemotherapy of tuberculosis.
    Lester W.
    Clin Notes Respir Dis; 1970 May 14; 9(2):3-13. PubMed ID: 4319281
    [No Abstract] [Full Text] [Related]

  • 20. [Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
    Mamolat AS, Bialik IB, Khutorskaia VD.
    Klin Med (Mosk); 1976 Dec 14; 54(12):72-8. PubMed ID: 189127
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.